Effects of combined therapy with resveratrol, continuous and interval exercises on apoptosis, oxidative stress, and inflammatory biomarkers in the liver of old rats with non-alcoholic fatty liver disease
- 13 February 2018
- journal article
- research article
- Published by Taylor & Francis in Archives of Physiology and Biochemistry
- Vol. 125 (2) , 142-149
Abstract
Context: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disorder. Objective: Effects of combined therapy with resveratrol, interval and continuous exercises on oxidative stress, inflammation, and apoptosis in the liver of rats with NAFLD. Methods: NAFLD rats were organised in patient, saline, resveratrol (RSV), continuous exercise, interval exercise, continuous exercise + RSV, and interval exercise + RSV groups. Results: Resveratrol supplementation alone or in combination with interval and continuous training significantly decreased malondialdehyde and TNF-α level (p < .05), while the levels of catalase; superoxide dismutase and IL-10 were significantly increased (p < .05). Although RSV alone significantly decreased the percentage of apoptotic cells (17.12%), its combination with interval (10.74%), and continuous (14.85%) exercise training demonstrated higher anti-apoptotic activity (p < .05). Conclusions: Although resveratrol alone has an antioxidant, anti-apoptotic and anti-inflammatory properties, combined therapy with interval, and continuous training can be more effective to mitigate these abnormalities in NAFLD patients.Keywords
Funding Information
- Islamic Azad University
This publication has 45 references indexed in Scilit:
- Mechanisms of Lipotoxicity in NAFLD and Clinical ImplicationsJournal of Pediatric Gastroenterology and Nutrition, 2011
- Evaluation of Biomarkers of NAFLD in a Cohort of Morbidly Obese PatientsJournal of Nutrition and Metabolism, 2011
- Resveratrol inhibits nonalcoholic fatty liver disease in ratsBMC Gastroenterology, 2008
- Definitive Diagnosis and Assessment of Risk for Nonalcoholic Fatty Liver Disease in Children and AdolescentsSeminars in Liver Disease, 2007
- Genes or environment to determine alcoholic liver disease and non‐alcoholic fatty liver diseaseLiver International, 2006
- Therapeutic potential of resveratrol: the in vivo evidenceNature Reviews Drug Discovery, 2006
- Low-intensity exercise training during doxorubicin treatment protects against cardiotoxicityJournal of Applied Physiology, 2006
- Prevalence of and risk factors for fatty liver in a general population of Shanghai, ChinaJournal of Hepatology, 2005
- Nonalcoholic Fatty Liver DiseaseNew England Journal of Medicine, 2002
- Non‐alcoholic fatty liver diseaseJournal of Gastroenterology and Hepatology, 2002